Loading your page…
Marketing-authorisation holder
11 medicines in 2 countries, as authorisation holder and manufacturer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
11 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CHIROCAINE2.5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 7.5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Levobupivacaine | United States | Not marketed | 1999 |
| INTERMEZZO1.75mg | 3.5mg · Tablet | Zolpidem | United States | Not marketed | 2011 |
| PALLADONE12mg | 16mg | 24mg | 32mg · Capsule, extended release | Hydromorphone | United States | Not marketed | 2004 |
| RYZOLT100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended release | Tramadol | United States | Not marketed | 2008 |
| TARGINIQ10mg; 20mg | 20mg; 40mg | 5mg; 10mg · Tablet, extended release | Naloxone, Oxycodone | United States | Not marketed | 2014 |
| OXYCONTIN 10 mg controlled release tablet | Oxycodone | Saudi Arabia | Authorised | |
| OXYCONTIN 15 mg controlled release tablet | Oxycodone | Saudi Arabia | Authorised | |
| OXYCONTIN 20 mg controlled release tablet | Oxycodone | Saudi Arabia | Authorised | |
| OXYCONTIN 30 mg controlled release tablet | Oxycodone | Saudi Arabia | Authorised | |
| OXYCONTIN 40 mg controlled release tablet | Oxycodone | Saudi Arabia | Authorised | |
| OXYCONTIN 60 mg controlled release tablet | Oxycodone | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 6 | 6 | 0 | CompaniesAll medicines |
| United States | 5 | 5 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
